Patent details

Basic Information

Publication number:

EP2638033

PCT Application Number:

PCT/US/2011/058692

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP117882639

PCT Publication Number:

WO/2012/064548

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOUNDS USEFUL FOR INHIBITING CHK1

French Title of Invention:

COMPOSÉS UTILES POUR INHIBER CHK1

German Title of Invention:

VERBINDUNGEN ALS CHK1-HEMMER

SPC Number:

Dates

Filing date:

01/11/2011

Grant date:

08/04/2015

EP Publication Date:

08/04/2015

PCT Publication Date:

18/05/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/09/2013

EP B1 Publication Date:

08/04/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/11/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/11/2011

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/04/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SAMAJDAR Susanta

Address:

United States (US)

2

Name:

JOSEPH Sajan

Address:

United States (US)

Priority

Priority Number:

411137 P

Priority Date:

08/11/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 401/14;

Annual Fees

Annual Fee Due Date:

01/12/2025

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

22/10/2024

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages